THE CHANGING SPECTRUM OF AIDS INDEX DISEASES IN CANADA

被引:45
作者
MONTANER, JSG
LE, T
HOGG, R
RICKETTS, M
SUTHERLAND, D
STRATHDEE, SA
OSHAUGHNESSY, M
SCHECHTER, MT
机构
[1] UNIV BRITISH COLUMBIA,FAC MED,DEPT MED,VANCOUVER,BC,CANADA
[2] UNIV BRITISH COLUMBIA,FAC MED,DEPT HLTH CARE & EPIDEMIOL,VANCOUVER,BC,CANADA
[3] UNIV BRITISH COLUMBIA,FAC MED,DEPT PATHOL,VANCOUVER V6T 1W5,BC,CANADA
[4] HLTH & WELF CANADA,DIV HIV AIDS EPIDEMIOL,OTTAWA K1A 0L2,ON,CANADA
关键词
AIDS; POPULATION SURVEILLANCE; INCIDENCE; CANADA; EPIDEMIOLOGY;
D O I
10.1097/00002030-199405000-00018
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To describe the changing spectrum of AIDS index diseases in Canada over a 10-year period from 1981 to 1991. Design: A descriptive, population-based study. Setting: Canada. Patients: All cases of AIDS in Canada reported by the Division of HIV/AIDS Epidemiology of the Department of National Health and Welfare. Main outcome measures: Age-standardized rates of initial AIDS manifestations (1987 Centers for Disease Control and Prevention case definition), by year of diagnosis among adults in Canada. Results: A total of 6641 adult AIDS cases were examined. The rate of Pneumocystis carinii pneumonia (PCP) peaked in 1989 with a rate of 3.18 per 100 000, declining to 2.74 per 100 000 in 1991 (P=0.894). Similarly, the rate of Kaposi's sarcoma (KS) stabilized during this interval from 1.06 per 1 00 000 in 1987 to 1.14 per 100000 in 1991 (P=0.189). In contrast, the rates of all other AIDS-defining illnesses increased from 1.48 per 100 000 in 1987 to 3.43 per 100 000 in 1991 (P=0.001). For these other AIDS index diseases, significant rate increases were observed for esophageal candidiasis, cytomegalovirus (CMV) diseases, wasting syndrome, toxoplasmosis, and Mycobacterium avium complex (MAC) disease. Conclusions: Our study shows a leveling and decline in incidence of KS and PCP, respectively, and a concomitant increase of other diagnoses, especially esophageal candidiasis, CMV, wasting syndrome, toxoplasmosis, and MAC disease in Canada. These findings highlight the importance of developing specific strategies to prevent emerging AIDS index diseases and serve as a cautionary note to practicing clinicians, indicating the relative widening of the spectrum of HIV index diseases.
引用
收藏
页码:693 / 696
页数:4
相关论文
共 24 条
  • [1] PRELIMINARY-ANALYSIS OF THE CONCORDE TRIAL
    ABOULKER, JP
    SWART, AM
    [J]. LANCET, 1993, 341 (8849) : 889 - 890
  • [2] INCIDENCE AND NATURAL-HISTORY OF MYCOBACTERIUM-AVIUM COMPLEX INFECTIONS IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE TREATED WITH ZIDOVUDINE
    CHAISSON, RE
    MOORE, RD
    RICHMAN, DD
    KERULY, J
    CREAGH, T
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 146 (02): : 285 - 289
  • [3] SPECTRUM OF DISEASE IN PERSONS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION IN THE UNITED-STATES
    FARIZO, KM
    BUEHLER, JW
    CHAMBERLAND, ME
    WHYTE, BM
    FROELICHER, ES
    HOPKINS, SG
    REED, CM
    MOKOTOFF, ED
    COHN, DL
    TROXLER, S
    PHELPS, AF
    BERKELMAN, RL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (13): : 1798 - 1805
  • [4] SAFETY AND EFFICACY OF SULFAMETHOXAZOLE AND TRIMETHOPRIM CHEMOPROPHYLAXIS FOR PNEUMOCYSTIS-CARINII PNEUMONIA IN AIDS
    FISCHL, MA
    DICKINSON, GM
    LAVOIE, L
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 259 (08): : 1185 - 1189
  • [5] INCIDENCE AND NATURAL-HISTORY OF CYTOMEGALOVIRUS DISEASE IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE TREATED WITH ZIDOVUDINE
    GALLANT, JE
    MOORE, RD
    RICHMAN, DD
    KERULY, J
    CHAISSON, RE
    BARTLETT, J
    MCAVINUE, S
    BRYSON, Y
    COHEN, H
    FISCHL, M
    BOLIN, T
    KESSLER, H
    BURROUGH, Y
    MILDVAN, D
    FOX, A
    RICHMAN, D
    FREEMAN, B
    SIMON, G
    GRABOWY, KW
    CHERNOFF, D
    DUFF, P
    THOMPSON, S
    BARRETT, K
    AWE, R
    CHAPMAN, R
    LEONARD, S
    BAINES, L
    TURNER, P
    HAWKINS, M
    MURRAY, H
    BOWERS, J
    LANE, C
    TILSON, H
    ANDREWS, E
    SMILEY, L
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (06) : 1223 - 1227
  • [6] PNEUMOCYSTIS-CARINII PNEUMONIA AND MUCOSAL CANDIDIASIS IN PREVIOUSLY HEALTHY HOMOSEXUAL MEN - EVIDENCE OF A NEW ACQUIRED CELLULAR IMMUNODEFICIENCY
    GOTTLIEB, MS
    SCHROFF, R
    SCHANKER, HM
    WEISMAN, JD
    FAN, PT
    WOLF, RA
    SAXON, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (24) : 1425 - 1431
  • [7] THE SPECTRUM OF HIV-1-RELATED DISEASE AMONG OUTPATIENTS IN NEW-YORK-CITY
    GREENBERG, AE
    THOMAS, PA
    LANDESMAN, SH
    MILDVAN, D
    SEIDLIN, M
    FRIEDLAND, GH
    HOLZMAN, R
    STARRETT, B
    BRAUN, J
    BRYAN, EL
    EVANS, RF
    [J]. AIDS, 1992, 6 (08) : 849 - 859
  • [8] DISSEMINATED MYCOBACTERIUM-AVIUM COMPLEX INFECTION - CLINICAL-IDENTIFICATION AND EPIDEMIOLOGIC TRENDS
    HAVLIK, JA
    HORSBURGH, CR
    METCHOCK, B
    WILLIAMS, PP
    FANN, SA
    THOMPSON, SE
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (03) : 577 - 580
  • [9] A CONTROLLED-STUDY OF INHALED PENTAMIDINE FOR PRIMARY PREVENTION OF PNEUMOCYSTIS-CARINII PNEUMONIA
    HIRSCHEL, B
    LAZZARIN, A
    CHOPARD, P
    OPRAVIL, M
    FURRER, HJ
    RUTTIMANN, S
    VERNAZZA, P
    CHAVE, JP
    ANCARANI, F
    GABRIEL, V
    HEALD, A
    KING, R
    MALINVERNI, R
    MARTIN, JL
    MERMILLOD, B
    NICOD, L
    SIMONI, L
    VIVIRITO, MC
    ZERBONI, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (16) : 1079 - 1083
  • [10] LOW-DOSE DAPSONE PROPHYLAXIS OF PNEUMOCYSTIS-CARINII PNEUMONIA IN AIDS AND AIDS-RELATED COMPLEX
    KEMPER, CA
    TUCKER, RM
    LANG, OS
    KESSINGER, JM
    GREENE, SI
    DERESINSKI, SC
    STEVENS, DA
    [J]. AIDS, 1990, 4 (11) : 1145 - 1148